Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antiviral Drug Development

Background:

• Remdesivir (Veklury) exhibits broad-spectrum antiviral activity.
• Remdesivir is undergoing Phase III clinical trials for COVID-19 treatment.
• Efficient synthesis of remdesivir's unnatural nucleobase is crucial for drug availability.

Purpose of the Study:

• To report an alternative synthetic strategy for the unnatural nucleobase fragment of remdesivir.
• To present a novel route distinct from existing methods for nucleobase synthesis.
• To explore enabling methodologies for remdesivir and other small-molecule therapeutic synthesis.

Main Methods:

• Formation of a key cyanoamidine intermediate.
• Lewis acid-catalyzed cyclization reaction.
• Characterization of the synthesized nucleobase fragment.

Main Results:

• Successful synthesis of the desired unnatural nucleobase.
• Demonstration of a distinct synthetic pathway.
• The cyanoamidine intermediate facilitates efficient cyclization.

Conclusions:

• The reported approach provides a viable alternative for remdesivir nucleobase synthesis.
• This method offers strategic advantages over previous synthetic routes.
• The methodology could be applicable to the synthesis of other novel therapeutics.